Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Y-mAbs Therapeutics Inc fell by 27.13m. Cash Flow from Financing totalled 100.00k or 0.12% of revenues. In addition the company used 27.23m for operations while cash used for investing totalled .
Cash flow per share | -0.5478 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.14 |
---|---|
Tangible book value per share | 2.08 |
More ▼
Balance sheet in USDView more
Current ratio | 2.92 |
---|---|
Quick ratio | 2.72 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼